Antihemophilic Factor, Human Recombinant

Known as: Factor VIII, Antihemophilic factor human, Factor VIII (Recombinant) 
The recombinant form of human antihemophilic factor (AH)) (Factor VIII) with coagulation promoting activity. Antihemophilic factor binds to factor… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Hemophilia A results from a deficiency in factor VIII activity. Current treatment regimens require frequent dosing… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Prophylaxis with factor (F)VIII is considered the optimal treatment for managing hemophilia A patients without… (More)
Is this relevant?
2009
2009
The use of plasma-derived factor VIII (pdFVIII) concentrates in hemophilia A has been reported to result in reduced anti-FVIII… (More)
  • table 1
  • figure 2
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
BACKGROUND The pharmacokinetics of factor VIII replacement therapy in preschool previously treated patients (PTPs) with… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2008
2008
Evaluation of factor F(V)III replacement in patients with haemophilia A undergoing surgery is critical for FVIII concentrates… (More)
Is this relevant?
2006
2006
Factor VIII (FVIII) inhibitors are anti-FVIII IgG that arise in up to 50% of the patients with hemophilia A, upon therapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?
2006
2006
BACKGROUND The utility of purified coagulation factor (F)VIII for treatment of hemophilia A is limited in part by its instability… (More)
Is this relevant?
2004
2004
The efficacy and safety of an advanced category recombinant antihaemophilic factor produced by a plasma- and albumin-free method… (More)
Is this relevant?
Review
2003
Review
2003
Besides preventing bleeding episodes, common goals of the treatment of hemophilia include integrating of patients into a normal… (More)
Is this relevant?
1997
1997
The protein cofactor, factor (F) VIIIa, is required for the efficient conversion of the substrate FX to FXa by the serine… (More)
Is this relevant?